Aravive, Inc.
ARAVDelisted Jan 29, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513818
Aravive, Inc. was delisted on Jan 29, 2024; its insiders filed their last Form 4 on Apr 11, 2023; 30 institutions reported holding it in 13F filings for Q4 2023, worth $825.5K in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Aravive, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 32 | 36 | +4 |
| Shares | 15.2M | 18.4M | +3.20M (+21.0%) |
| Value | $20.1M | $36.9M | +$16.8M (+83.3%) |
New holders (12)
Institutions that held Aravive, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Assenagon Asset Management S.A. | 200,453 | $400.9K | 0.00% |
| Susquehanna International Group, LLP | 131,635 | $263.3K | 0.00% |
| Bridgeway Capital Management, LLC | 92,200 | $184.4K | 0.00% |
| Goldman Sachs Group Inc | 60,878 | $121.8K | 0.00% |
| Qube Research & Technologies Ltd | 53,919 | $107.8K | 0.00% |
| Virtu Financial LLC | 14,242 | $28.0K | 0.00% |
| Freedom Wealth Alliance, LLC | 13,912 | $27.8K | 0.04% |
| Squarepoint Ops LLC | 11,350 | $22.7K | 0.00% |
| Point72 Asset Management, L.P. | 6,378 | $12.8K | 0.00% |
| Cubist Systematic Strategies, LLC | 2,735 | $5.47K | 0.00% |
| Point72 Middle East FZE | 2,601 | $5.20K | 0.00% |
| Advisor Group Holdings, Inc. | 575 | $1.15K | 0.00% |
Sold out (8)
Institutions that held Aravive, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Charles Schwab Investment Management Inc | 27,004 | $35.6K |
| Franklin Resources Inc | 26,153 | $34.5K |
| Citigroup Inc | 21,988 | $29.0K |
| Anchor Investment Management, LLC | 20,000 | $26.4K |
| Acadian Asset Management LLC | 15,729 | $20.0K |
| Collective Family Office LLC | 12,000 | $15.8K |
| Citadel Advisors LLC | 5,535 | $7.31K |
| Money Concepts Capital Corp | 425 | $561 |